Richard Straube Email and Phone Number
Richard Straube work email
- Valid
- Valid
- Valid
- Valid
- Valid
Richard Straube personal email
- Valid
Richard Straube phone numbers
Richard Straube is a Chief Medical Officer at Stealth Peptides Incorporated at Soligenix, Inc.. He possess expertise in trials, regulatory filings, critical care, clinical research.
Soligenix, Inc.
View- Website:
- soligenix.com
- Employees:
- 24
-
Chief Medical OfficerSoligenix, Inc. Jan 2014 - Present
-
Chief Medical OfficerStealth Peptides Incorporated Jan 2009 - Dec 2013• Restructured an academic company into a development company• Wrote and submitted 2 INDs• Designed implemented and reported 7 phase 1 trials with a novel mitochondrial protective agent• Designed and implemented an international phase 2 trial of Bendavia in STEMI patients -
Chief Medical OfficerCritical Biologics Corporation Feb 2007 - Jan 2009• Created the development program for treatment of critically ill patients with a novel drug, gelsolin• Oversaw the development, validation and clinical utility of a diagnostic test for the quantitation of serum gelsolin• Wrote the Investigator Brochure and regulatory filings needed to start human trials with gelsolin in Hong Kong• Completed and analyzed the initial studies with gelsolin in critically ill patients
-
Chief Medical OfficerIno Therapeutics Llc Jun 1998 - Feb 2007• Founding physician that grew a 6-person group to a fully-integrated pharmaceutical company with a staff of 250 and revenues of over $225M per year. • Was responsible for creating and defending the NDA for inhaled nitric oxide and the companion delivery device for use in newborns• Was responsible for growing the R&D organization to include Clinical Research, Biostatistics, Medical Liaisons, Regulatory Affairs, Quality• Participated in the sale of the company to Ikaria for $700M
-
Senior DirectorOhmeda Pharmaceuticals Feb 1994 - Jun 1998• Established the Clinical Research group for critical care • Created the development programs for inhaled nitric oxide• Coordinated the academic and company research trials for inhaled nitric oxide
-
Director Medical AffairsT-Cell Sciences, Incorporated Feb 1992 - Feb 1994• Design of the company sponsored clinical trials with TP-10• Coordinated the joint venture activities for TP-10 with Astra AB
-
Senior Director, Infectious Diseases And Immunology & Clinical ResearchCentocor, Inc Feb 1987 - Feb 1992• Responsible for the development of anti-endotoxin and anti-cytokine monoclonal antibodies• Designed and ran the phase 3 trials with HA-1A• Gained EMEA approval for HA-1A• Oversaw the initial research into the anti-TNF monoclonal antibody (Remicade™) for the treatment of rheumatoid arthritis
-
Director, Rapid Viral Diagnostic LaboratoryUniveristy Of California, San Diego Medical Center Jun 1984 - Feb 1987• Developed viral diagnostic tests for RSV and CMV• Provided diagnostic clinical testing for viral infections using antibody techniques
-
Hospital EpidemiologyUniversity Of California, San Diego Mediacl Center Jun 1984 - Feb 1987• Established hospital infection control policies• Hospital outbreak investigations
-
Adjunctive Assistant ProfessorUniversity Of California, San Diego Medical Center Jun 1984 - Feb 1987• Clinical support for the 6 U|CSD-associated hospitals• Ran the first HIV treatment clinical trial• Primary Investigator for anti-viral therapies aimed at neonatal HSV, shingles, genital herpes infections, and RSV
Richard Straube Skills
Richard Straube Education Details
-
London School Of Hygiene And Tropical Medicine, U. Of LondonEpidemiology -
Uc San DiegoJoint Adult And Pediatric Infectious Diseases Fellowship
-
University Of Chicago, Wyler’S Children HospitalPediatric Residency
-
University Of Chicago, Wyler’S Children HospitalPediatric Internship
-
The University Of Chicago Pritzker School Of MedicineDoctor Of Medicine (Md)
-
University Of ChicagoGeneral
Frequently Asked Questions about Richard Straube
What company does Richard Straube work for?
Richard Straube works for Soligenix, Inc.
What is Richard Straube's role at the current company?
Richard Straube's current role is Chief Medical Officer at Stealth Peptides Incorporated.
What is Richard Straube's email address?
Richard Straube's email address is mo****@****ail.net
What is Richard Straube's direct phone number?
Richard Straube's direct phone number is +190823*****
What schools did Richard Straube attend?
Richard Straube attended London School Of Hygiene And Tropical Medicine, U. Of London, Uc San Diego, University Of Chicago, Wyler’s Children Hospital, University Of Chicago, Wyler’s Children Hospital, The University Of Chicago Pritzker School Of Medicine, University Of Chicago.
What skills is Richard Straube known for?
Richard Straube has skills like Trials, Regulatory Filings, Critical Care, Clinical Research.
Who are Richard Straube's colleagues?
Richard Straube's colleagues are Sarah Millen, Michelle Villalta, Robert Brey, Bea Trout, Lauren Krause-Malave, Allison Pressly, James Prohl.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial